Topline data were announced from two phase 3 studies evaluating bepirovirsen for the treatment of chronic hepatitis B.
Chronic hepatitis B (CHB) is a long-term infection of the liver caused by the hepatitis B virus (HBV). While acute hepatitis B infection is often resolved by the immune system, CHB occurs when the ...
SAN FRANCISCO, Dec. 12, 2025 /PRNewswire/ -- AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (together AusperBio), a clinical-stage biotechnology company developing oligonucleotide-based ...
A functional cure rate of approximately 30% has been widely recognized by global experts as a key milestone for a curative regimen to achieve. AHB-137 is the first investigational therapy to achieve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback